Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?

To: Willsgarden who wrote (57479)	2/5/2007 4:29:24 PM
From: MJ	Read Replies (1) \| Respond to of 59879

Bill This is the 2/05/07 news. GNBT is much more than it seems at first blush. See the SI quote for full article. "Volunteers Selected for Human Clinical Trial of Generex Biotechnology's Synthetic Avian Influenza Vaccine Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that 50 volunteers have been selected and final preparations made for initiation of human clinical trials of the synthetic avian influenza vaccine under development by its wholly owned subsidiary, Antigen Express, Inc. The Company previously entered into an agreement with the Lebanese-Canadian Hospital in Beirut, Lebanon to conduct the Phase I trial. An additional 70 prospective volunteers are presently being screened by the Hospital. An aggregate of 160 patients are expected to participate in the trial." Going to stay with this for awhile. mj

To: Willsgarden who wrote (57479)	2/6/2007 9:15:23 AM
From: hotlinktuna	Read Replies (1) \| Respond to of 59879

DRGV .041 might get attention on this upgrade: Bridge IR Group Upgrades Rating of Dragon Capital Group Corp. to a Speculative Strong Buy With a Target Price of $0.40 per Share Tuesday February 6, 8:30 am ET NEW YORK, NY--(MARKET WIRE)--Feb 6, 2007 -- Bridge IR Group has upgraded their equity rating on Dragon Capital Group (Other OTC:DRGV.PK - News) to a speculative strong buy rating with a target price of $0.40 per share. This strong upgrade comes at a time when Dragon Capital Group, a leading holding company of emerging technology in China, reported 2006's consolidated revenue of $42.29 million with a year end 2007 sales forecast of $55 to $60 million. ADVERTISEMENT The 16-page research report covers many aspects of Dragon Capital Group. The following is some excerpts from the research report: - Dragon Capital has developed cutting-edge technology, such as 3G-based SMS technology applications for lottery services and real estate transactions. They are in the mid-level stage of developing various mobile business solutions including mobile hotel reservations, mobile dating services, mobile police, and logistic operations. -The Company's 6 technology-related subsidiaries recorded record revenues of $42.29 million for the 12 months of FY2006. Gross profits rose to $2.98 million in 2006 with income from only 6 subsidiaries reaching $1.37 million. - The Company anticipates the main driver of its expansion in 2007 will come from internal expansion coupled with the execution of select accretive acquisitions. Management sees 2007 revenues from the current operations of its 7 Chinese subsidiaries in the range of $55 to $60 million with net income in excess of $1.5 million as net margins continue to improve. To view the entire independent research report, please click on the attached URL at bridgeir.com About Dragon Capital Group Corp. Dragon Capital Group Corp (Other OTC:DRGV.PK - News) is doing business in China through its subsidiaries. Dragon was established to serve as a conduit between Chinese high-growth companies and Western investors. DRGV functions as an incubator of high-tech companies in China, offering support in the critical functions of general business consulting, formation of joint ventures, access to capital, merger & acquisition, business valuation, and revenue growth strategies. DRGV has developed a portfolio of high-tech companies operating in China. For more information about DRGV, please visit dragoncapital.us. Safe Harbor Statement Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the word expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. Contact: Contact: Bridge IR Group Tel: 877-88-BRIDGE Email: info@bridgeir.com -------------------------------------------------------------------------------- Source: Dragon Capital Group Corp.